| Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand N Ferguson, D Laydon, G Nedjati Gilani, N Imai, K Ainslie, M Baguelin, ... Imperial College COVID-19 Response Team, 2020 | 5149 | 2020 |
| Estimates of the severity of coronavirus disease 2019: a model-based analysis R Verity*, LC Okell*, I Dorigatti*, P Winskill*, C Whittaker*, N Imai, ... The Lancet infectious diseases 20 (6), 669-677, 2020 | 4899* | 2020 |
| Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe S Flaxman, S Mishra, A Gandy, HJT Unwin, TA Mellan, H Coupland, ... Nature 584 (7820), 257-261, 2020 | 4323* | 2020 |
| The impact of COVID-19 and strategies for mitigation and suppression in low-and middle-income countries PGT Walker*, C Whittaker*, OJ Watson*, M Baguelin, P Winskill, A Hamlet, ... Science 369 (6502), 413-422, 2020 | 1714* | 2020 |
| Genomics and epidemiology of the P. 1 SARS-CoV-2 lineage in Manaus, Brazil NR Faria*, TA Mellan*, C Whittaker*, IM Claro*, DS Candido*, S Mishra*, ... Science 372 (6544), 815-821, 2021 | 1689* | 2021 |
| SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion P Mlcochova, SA Kemp, MS Dhar, G Papa, B Meng, IATM Ferreira, R Datir, ... Nature 599 (7883), 114-119, 2021 | 1537* | 2021 |
| Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’ E Lavezzo, E Franchin, C Ciavarella, G Cuomo-Dannenburg, L Barzon, ... Nature 584 (7821), 425-429, 2020 | 1049 | 2020 |
| Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study AB Hogan*, BL Jewell*, E Sherrard-Smith*, JF Vesga*, OJ Watson*, ... The Lancet Global Health 8 (9), e1132-e1141, 2020 | 938* | 2020 |
| Reduction in mobility and COVID-19 transmission P Nouvellet, S Bhatia, A Cori, KEC Ainslie, M Baguelin, S Bhatt, ... Nature communications 12 (1), 1-9, 2021 | 637 | 2021 |
| Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic LF Buss, CA Prete Jr, CMM Abrahim, A Mendrone Jr, T Salomon, ... Science 371 (6526), 288-292, 2021 | 586 | 2021 |
| Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India MS Dhar, R Marwal, R Vs, K Ponnusamy, B Jolly, RC Bhoyar, V Sardana, ... Science 374 (6570), 995-999, 2021 | 341 | 2021 |
| The FLC Locus: A Platform for Discoveries in Epigenetics and Adaptation C Whittaker, C Dean Annual Review of Cell and Developmental Biology 33 (1), 2017 | 310 | 2017 |
| Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study NC Grassly, M Pons-Salort, EPK Parker, PJ White, NM Ferguson, ... The Lancet Infectious Diseases 20 (12), 1381-1389, 2020 | 266* | 2020 |
| Global disparities in SARS-CoV-2 genomic surveillance AF Brito, E Semenova, G Dudas, GW Hassler, CC Kalinich, MUG Kraemer, ... Nature communications 13 (1), 7003, 2022 | 243 | 2022 |
| Response to COVID-19 in South Korea and implications for lifting stringent interventions A Dighe, L Cattarino, G Cuomo-Dannenburg, J Skarp, N Imai, S Bhatia, ... BMC medicine 18, 1-12, 2020 | 214 | 2020 |
| The potential public health consequences of COVID-19 on malaria in Africa E Sherrard-Smith, AB Hogan, A Hamlet, OJ Watson, C Whittaker, ... Nature medicine 26 (9), 1411-1416, 2020 | 194 | 2020 |
| State-level tracking of COVID-19 in the United States HJT Unwin, S Mishra, VC Bradley, A Gandy, TA Mellan, H Coupland, ... Nature communications 11 (1), 6189, 2020 | 186 | 2020 |
| Subnational analysis of the initial phase of the COVID-19 epidemic in Brazil TA Mellan, H Hoeltgebaum, S Mishra, C Whittaker, I Hawryluk, A Gandy, ... 2023 ICLR First Workshop on {\textquotedblleft} Machine Learning {\&} Global …, 2023 | 167* | 2023 |
| Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis AB Hogan, P Winskill, OJ Watson, PGT Walker, C Whittaker, M Baguelin, ... Vaccine 39 (22), 2995-3006, 2021 | 161* | 2021 |
| Estimating the COVID-19 infection fatality ratio accounting for seroreversion using statistical modelling NF Brazeau, R Verity, S Jenks, H Fu, C Whittaker, P Winskill, I Dorigatti, ... Communications medicine 2 (1), 54, 2022 | 155* | 2022 |
Azra GhaniImperial College LondonПодтвержден адрес электронной почты в домене imperial.ac.uk
